Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 4,450 | 4,450 | 0 | $1.31M | $1.43M | 8.57% | +$122.2K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 67,500 | 67,500 | 0 | $889.6K | $1.26M | 7.52% | +$368.6K |
| Royalty Pharma plcCL A(RPRX) | 21,400 | 21,400 | 0 | $826.9K | $1.03M | 6.14% | +$199.7K |
| Milestone Pharmaceuticals Inc.(MIST) | 755,000 | 820,000 | +65,000 | $1.53M | $975.8K | 5.83% | -$549.3K |
| Geron Corporation(GERN) | 578,000 | 578,000 | 0 | $763.0K | $861.2K | 5.15% | +$98.3K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 36,000 | 36,000 | 0 | $756.4K | $841.0K | 5.03% | +$84.6K |
| Ardelyx Inc | 128,650 | 128,650 | 0 | $750.0K | $770.6K | 4.61% | +$20.6K |
| Fennec Pharmaceuticals Inc.(FENC) | 112,434 | 112,434 | 0 | $865.7K | $691.5K | 4.13% | -$174.3K |
| Benitec Biopharma Inc.(BNTC) | 62,000 | 62,000 | 0 | $835.1K | $660.3K | 3.95% | -$174.8K |
| Sarepta Therapeutics, Inc.(SRPT) | 28,500 | 28,500 | 0 | $613.3K | $620.2K | 3.71% | +$6.8K |
| Disc Medicine, Inc.(IRON) | 8,100 | 8,100 | 0 | $643.2K | $517.9K | 3.10% | -$125.3K |
| Cue Biopharma, Inc.(CUE) | 2,202,854 | 2,202,854 | 0 | $672.8K | $506.4K | 3.03% | -$166.3K |
| COMPASS Pathways plcADS(CMPS) | 58,000 | 80,000 | +22,000 | $400.2K | $442.4K | 2.64% | +$42.2K |
| Biohaven Ltd.(BHVN) | 51,700 | 51,700 | 0 | $583.7K | $437.4K | 2.61% | -$146.3K |
| Lantheus Holdings, Inc.(LNTH) | 5,500 | 5,500 | 0 | $366.0K | $417.2K | 2.49% | +$51.1K |
| Jasper Therapeutics, Inc.(JSPR) | 465,000 | 465,000 | 0 | $851.0K | $407.4K | 2.44% | -$443.5K |
| Humacyte, Inc.(HUMA) | 500,000 | 650,000 | +150,000 | $480.3K | $394.4K | 2.36% | -$85.9K |
| Viatris Inc.(VTRS) | 27,700 | 27,700 | 0 | $344.9K | $374.2K | 2.24% | +$29.4K |
| Kura Oncology, Inc.(KURA) | 46,000 | 46,000 | 0 | $477.9K | $374.0K | 2.24% | -$104.0K |
| BridgeBio Pharma, Inc.(BBIO) | 5,000 | 5,000 | 0 | $382.4K | $371.3K | 2.22% | -$11.2K |
| Dyne Therapeutics, Inc.(DYN) | 18,000 | 18,000 | 0 | $352.1K | $326.3K | 1.95% | -$25.7K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 86,000 | 86,000 | 0 | $301.9K | $307.9K | 1.84% | +$6.0K |
| Pacira BioSciences, Inc.(PCRX) | 13,500 | 13,500 | 0 | $349.4K | $305.1K | 1.82% | -$44.3K |
| Edgewise Therapeutics, Inc.(EWTX) | 9,100 | 9,100 | 0 | $225.8K | $286.6K | 1.71% | +$60.8K |
| Mineralys Therapeutics, Inc.(MLYS) | 10,500 | 10,500 | 0 | $381.0K | $284.4K | 1.70% | -$96.6K |
| Seres Therapeutics, Inc.(MCRB) | 31,570 | 31,570 | 0 | $469.8K | $280.0K | 1.67% | -$189.7K |
| Janux Therapeutics, Inc.(JANX) | 19,000 | 19,000 | 0 | $262.2K | $264.1K | 1.58% | +$1.9K |
| uniQure N.V.SHS(QURE) | 14,700 | 14,700 | 0 | $351.8K | $240.3K | 1.44% | -$111.4K |
| REGENXBIO Inc.(RGNX) | 26,600 | 26,600 | 0 | $383.0K | $222.9K | 1.33% | -$160.1K |
| Azenta, Inc.(AZTA) | 9,700 | 9,700 | 0 | $322.6K | $205.0K | 1.22% | -$117.7K |
| Innoviva, Inc.(INVA) | 8,200 | 8,200 | 0 | $163.9K | $191.1K | 1.14% | +$27.1K |
| GH Research PLC(GHRS) | 10,200 | 10,200 | 0 | $129.5K | $143.4K | 0.86% | +$13.9K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 5,250 | 5,250 | 0 | $152.5K | $123.7K | 0.74% | -$28.8K |
| Innate Pharma S.A.ADS(IPHA) | 81,151 | 81,151 | 0 | $142.0K | $103.9K | 0.62% | -$38.1K |
| Spruce Biosciences Inc | 1,000 | 1,000 | 0 | $87.1K | $65.3K | 0.39% | -$21.8K |
| Day One Biopharmaceuticals I COM | 42,000 | 0 | -42,000 | $391.4K | $0 | — | -$391.4K |
| Mersana Therapeutics Inc | 100 | 0 | -100 | $2.9K | $0 | — | -$2.9K |
| Minerva Neurosciences, Inc.(NERV) | 35,000 | 0 | -35,000 | $140.7K | $0 | — | -$140.7K |
| Ventyx Biosciences Inc | 41,500 | 0 | -41,500 | $374.7K | $0 | — | -$374.7K |